Sanofi India Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
SANOFI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sanofi India has informed the stock exchanges that its trading window will remain closed from 1st October 2025 until 48 hours after the announcement of financial results for the quarter and nine-months ending 30th September 2025. This is a routine compliance measure under SEBI's Insider Trading Regulations, meant to prevent designated persons from trading in the company's shares while in possession of unpublished price-sensitive information. Designated persons and insiders are prohibited from buying or selling Sanofi India shares during this blackout period.
This is a standard regulatory filing and not a material event. No direct impact on shareholders or stock price is expected. Investors should note that the upcoming Q2 and nine-months FY26 results announcement is likely to come after 1st October 2025 once the trading window reopens.